GleamWall
中文EN

ESMC ESCALON MEDICAL CORP

Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 862668 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.4%
TTM net income YoY4,528.3%
TTM EPS YoY1,700.0%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR81.5%

Margins

Gross margin44.1%
Operating margin3.8%
Net margin32.8%
FCF margin0.8%
EBITDA margin3.9%

Returns

ROE114.9%
ROA61.7%
ROIC (approx.)22.8%
Asset turnover1.88x

Leverage & solvency

Liabilities / assets38.4%
Debt / equity0.00x
Current ratio2.72x
Interest coverage149.58x

Cash quality & payout

Operating cash flow / net income0.03x
Accruals ratio60.2%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-09-302026Q4*2026-06-302026Q32026-03-312026Q22025-12-312026Q12025-09-302025Q4*2025-06-302025Q32025-03-312025Q22024-12-31
Income statement
Revenue$3.71M$3.86M$2.61M$3.59M$2.68M$2.57M$3.47M$3.22M
Cost of revenue$2.08M$1.91M$1.66M$2.04M$1.55M$1.45M$1.87M$1.65M
Gross profit$1.63M$1.95M$946,662$1.56M$1.12M$1.12M$1.60M$1.57M
R&D expense$94,398$124,300$29,908$131,182$216,098$291,576$164,755$155,940
SG&A expense$1.27M$1.25M$1.34M$1.33M$1.11M$1.20M$1.16M$1.16M
Operating income$269,548$568,511-$419,263$98,738-$202,751-$371,769$276,037$255,904
Interest expense$305-$825$3,204$776$4,304$7,982$4,565$4,883
Income tax$0-$1.14M$0$0$0$0$0$0
Net income$269,243$1.78M$2.37M$97,677-$239,852-$379,751$271,472$246,021
EBITDA$272,548$571,512-$416,263$107,155-$194,581-$363,217$284,825$265,756
EPS (basic)0.02—0.160.01-0.03—0.020.02
EPS (diluted)0.02—0.160.01-0.03—0.020.02
Weighted avg. shares (diluted)14.19M—14.51M14.42M7.42M—14.17M14.08M
Banking
Provision for credit losses$126———-$89,322———
Balance sheet
Cash & equivalents$3.67M$3.07M$3.34M$337,434$615,791$545,835$540,908$520,584
Receivables$1.91M$1.90M$1.34M$2.24M$1.34M$1.50M——
Inventory$1.84M$1.73M$1.66M$1.52M$1.75M$2.14M$1.74M$1.72M
Current assets$7.70M$7.01M$6.57M$4.29M$4.22M$4.61M$4.84M$4.30M
PP&E, net$23,694$26,605$29,516$32,427$35,752$34,589$34,348$38,224
Intangibles$8,045$8,134$8,224$19,788$24,880$29,792$34,705$39,617
Total assets$10.07M$9.13M$7.53M$4.98M$4.58M$4.99M$5.22M$4.49M
Current liabilities$2.83M$2.39M$2.53M$2.60M$2.53M$2.69M$2.52M$2.21M
Total liabilities$3.87M$3.20M$3.39M$3.21M$2.91M$3.08M$2.92M$2.46M
Shareholders' equity$6.20M$5.93M$4.15M$1.77M$1.68M$1.92M$2.29M$2.02M
Shares outstanding7.42M7.42M7.42M7.42M—7.42M7.42M7.42M
Cash flow statement
Operating cash flow$603,173-$251,180$280,983-$517,415$85,008$15,760$30,695$300,941
Capital expenditure$0$0$0$0$4,421$3,880$0$0
Free cash flow$603,173-$251,180$280,983-$517,415$80,587$11,880$30,695$300,941
Investing cash flow$0-$25,000$2.83M$0-$4,421-$3,880$0$0
Financing cash flow-$883-$889-$100,880-$17,524-$10,599-$6,921-$10,339-$10,021
Depreciation & amortization$3,000$3,001$3,000$8,417$8,170$8,552$8,788$9,852

Free plan shows the latest 8 periods; Pro shows all 65 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.